Skip to main content
. 2022 Nov 17;108(3):673–689. doi: 10.3324/haematol.2022.281457

Table 3.

Larger retrospective studies evaluating the use of high-dose methotrexate as central nervous system prophylaxis.

graphic file with name 108673.tab3.jpg